The primary objective of this study is to identify predictors of response (including both efficacy and the development of adverse events) in patients with rheumatoid arthritis.

The RAMS study is approved by North West 7 Research Ethics Committee – Greater Manchester Central (08/H1008/25) and adopted by UKCRN (no. 5118).

We aim to recruit 2000 patients. 


Design based on Free CSS Templates.